During early Monday trading, shares of biopharmaceutical firm Vivani Medical, Inc. (VANI) fell 5.9% after the company announced the completion of a $16 million fundraising at $1.62 per share. The proceeds will be allocated to research and development. The offering included a private placement, signaling strategic investment in the company's growth.